A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate ...

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500 ...

Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

“This is a rare opportunity for me personally, this is my only hope to extend my life by any real period at all." The post ...

Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.